November 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · DOI: 10.1200/JCO-26-00899

Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.

Listen to this summary

The DasaHIT trial asked whether a reduced-exposure dasatinib schedule (100 mg daily for 5 days, then a 2-day weekend break) can maintain treatment response while improving tolerability in chronic-phase CML. In first-line patients, intermittent dosing was noninferior to standard daily dosing for major molecular remission at 24 months (78% vs 81%), but it was not noninferior in later-line patients, who had lower response rates. The intermittent schedule also showed a lower rate of pleural/pericardial effusion (8% vs 16%), a post hoc finding that suggests but does not confirm better tolerability.

Paul La Rosée, Philipp Ernst, Christian Fabisch, Annamaria Brioli, Dominik Wolf, Lino L Teichmann, Ludwig Fischer von Weikersthal, Susanne Saussele, Theresa Früh, Frank Stegelmann, Cornelius F Waller, Bernd Hertenstein, Tim H Brümmendorf, Andreas Burchert, Jenny Rinke, Ali Albeer, Thomas Ernst, Markus Pfirrmann, Andreas Hochhaus

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

More from Journal of clinical oncology : official journal of the American Society of Clinical Oncology

View all →

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.

Nov 17, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.

Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.

Nov 12, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play